Reproducibility of quantitative dynamic MRI of normal human tissues

The aim of the study was to establish the normal range and to evaluate the reproducibility of dynamic contrast enhanced MRI (DCE‐MRI) parameter estimates in normal human pelvic tissues. Nineteen patients with prostate cancer, undergoing androgen deprivation treatment, had paired DCE‐MRI examinations of the pelvis using spoiled gradient‐echo sequences. Quantitative enhancement parameters were calculated for each examination: transfer constant (Ktrans), leakage space (ve) and maximum contrast medium accumulation (MCMA) of pelvic muscles, bone marrow and fat. Descriptive and reproducibility statistics were calculated: within‐patient standard deviation (wSD), repeatability and within‐patient coefficient of variation (wCV). The femoral head and ischiorectal fat showed large numbers of non‐enhancing pixels (81 and 88%, respectively). The ischial bone marrow had the highest values of kinetic parameter estimates (Ktrans 0.554 min−1, ve 18.5% and MCMA 0.164 mmol/kg). Muscle parameters values were lower (Ktrans 0.126–0.137 min−1, ve 10.6–11.5% and MCMA 0.077–0.086 mmol/kg). The mean difference between paired examinations was not significantly different from zero for any parameter. ve and MCMA had the lowest wCV (between 19 and 29%). For individuals, a log10 Ktrans change of approximately 0.90 in muscles and 0.52 in the ischium would be statistically significant. The corresponding absolute changes for ve are 6.7% in muscle and 13.6% in the ischium. For a group of 19 patients, small changes are statistically significant (muscle log10 Ktrans 0.208 and ve 1.5% and ischium log10 Ktrans 0.123 and ve 3.1%). Fat and the femoral head are unreliable tissues from which to obtain kinetic parameter estimates due to poor enhancement. ve and MCMA have smaller coefficient of variation than Ktrans in muscles and ischium. Reproducibility studies of normal and pathological tissues should be incorporated into clinical research protocols that measure treatment effects by DCE‐MRI techniques. Copyright © 2002 John Wiley & Sons, Ltd.

[1]  D P Dearnaley,et al.  Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.

[2]  R. Edelman,et al.  Semiquantitative assessment of uterine perfusion using first pass dynamic contrast‐enhanced MR imaging for patients treated with uterine fibroid embolization , 2000 .

[3]  W Zhen,et al.  Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer , 2000, Journal of magnetic resonance imaging : JMRI.

[4]  C Kremser,et al.  Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. , 2000, Radiology.

[5]  A R Padhani,et al.  In vivo monitoring of tumor angiogenesis with MR imaging. , 2000, Academic radiology.

[6]  S. Ascher,et al.  Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. , 2000, Radiology.

[7]  J. Healy,et al.  Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. , 2000, Radiology.

[8]  H. Augustin,et al.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.

[9]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[10]  M O Leach,et al.  Improving image quality and T(1) measurements using saturation recovery turboFLASH with an approximate K-space normalisation filter. , 2000, Magnetic resonance imaging.

[11]  W E Reddick,et al.  Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma , 1999, Journal of magnetic resonance imaging : JMRI.

[12]  J L Evelhoch,et al.  Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.

[13]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[14]  S. Leung,et al.  Proton magnetic resonance spectroscopy of late delayed radiation‐induced injury of the brain , 1999, Journal of magnetic resonance imaging : JMRI.

[15]  T. Henry Science, medicine, and the future: Therapeutic angiogenesis , 1999 .

[16]  G J Parker,et al.  Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. , 1999, Topics in magnetic resonance imaging : TMRI.

[17]  D. Pode,et al.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.

[18]  J. Isner,et al.  Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). , 1998, VASA. Zeitschrift fur Gefasskrankheiten.

[19]  R K Jain,et al.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Witjes,et al.  Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. , 1998, Radiology.

[21]  A. Fischman,et al.  Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  A R Padhani,et al.  MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  A R Padhani,et al.  Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics , 1997, Journal of magnetic resonance imaging : JMRI.

[24]  P. Tofts Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[25]  D. Bluemke,et al.  MRI of Avascular Necrosis of Bone , 1996, Topics in magnetic resonance imaging : TMRI.

[26]  D G Altman,et al.  Statistics Notes: Measurement error proportional to the mean , 1996, BMJ.

[27]  D. Altman,et al.  Statistics notes: Measurement error , 1996 .

[28]  K. McGraw,et al.  Forming inferences about some intraclass correlation coefficients. , 1996 .

[29]  K. Verstraete,et al.  Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. , 1995, AJR. American journal of roentgenology.

[30]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[31]  G Brix,et al.  MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. , 1994, Magnetic resonance imaging clinics of North America.

[32]  W J Manning,et al.  Studies of Gd‐DTPA relaxivity and proton exchange rates in tissue , 1994, Magnetic resonance in medicine.

[33]  S. Heywang,et al.  MR imaging of the breast with Gd-DTPA: use and limitations. , 1989, Radiology.